rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2008-12-3
|
pubmed:databankReference |
|
pubmed:abstractText |
There is a need for standardization of treatment decisions in older patients with acute myeloid leukemia. The aim of the present study was to analyze the decisional value of poor risk factors in 416 elderly patients treated in the ALFA-9803 trial in order to derive a decisional index.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1592-8721
|
pubmed:author |
pubmed-author:Acute Leukemia French Association (ALFA),
pubmed-author:BordessouleDominiqueD,
pubmed-author:ContentinNathalieN,
pubmed-author:DombretHervéH,
pubmed-author:EtienneAnneA,
pubmed-author:GardinClaudeC,
pubmed-author:MalfusonJean-ValèreJV,
pubmed-author:RigaudeauSophieS,
pubmed-author:TerréChristineC,
pubmed-author:ThomasXavierX,
pubmed-author:TurlurePascalP,
pubmed-author:VeyNorbertN,
pubmed-author:de RevelThierryT
|
pubmed:issnType |
Electronic
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1806-13
|
pubmed:meshHeading |
pubmed-meshheading:18838471-Age Factors,
pubmed-meshheading:18838471-Aged,
pubmed-meshheading:18838471-Aged, 80 and over,
pubmed-meshheading:18838471-Antineoplastic Agents,
pubmed-meshheading:18838471-Clinical Trials as Topic,
pubmed-meshheading:18838471-Cytogenetic Analysis,
pubmed-meshheading:18838471-Daunorubicin,
pubmed-meshheading:18838471-Decision Making,
pubmed-meshheading:18838471-Female,
pubmed-meshheading:18838471-Humans,
pubmed-meshheading:18838471-Idarubicin,
pubmed-meshheading:18838471-Leukemia, Myeloid, Acute,
pubmed-meshheading:18838471-Leukocyte Count,
pubmed-meshheading:18838471-Male,
pubmed-meshheading:18838471-Patient Selection,
pubmed-meshheading:18838471-Practice Guidelines as Topic,
pubmed-meshheading:18838471-Risk Factors,
pubmed-meshheading:18838471-Survival Analysis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
|
pubmed:affiliation |
Department of Hematology, Hôpital d'Instruction des Armées, Clamart, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|